2023-08-01 2024-07-31 2024-07-31 Trading false The accounts were prepared in accordance with frs102 There is no accountants report AbridgedAccounts This company is a private limited company 10846833 2024-07-31 10846833 2023-07-31 10846833 2022-07-31 10846833 2023-08-01 2024-07-31 10846833 2022-08-01 2023-07-31 10846833 uk-cd-pres:AllEntityOfficers 2023-08-01 2024-07-31 10846833 uk-cd-pres:AllEntityOfficers 2022-08-01 2023-07-31 10846833 uk-cd-pres:CompanySecretary1 2023-08-01 2024-07-31 10846833 uk-cd-pres:CompanySecretaryDirector1 2023-08-01 2024-07-31 10846833 uk-cd-pres:CompanySecretaryDirector1 2024-07-31 10846833 uk-cd-pres:Director1 2023-08-01 2024-07-31 10846833 uk-cd-pres:Director1 2024-07-31 10846833 uk-cd-pres:Director2 2023-08-01 2024-07-31 10846833 uk-cd-pres:Director2 2024-07-31 10846833 uk-cd-pres:Director3 2023-08-01 2024-07-31 10846833 uk-cd-pres:Director3 2024-07-31 10846833 uk-cd-pres:Director4 2023-08-01 2024-07-31 10846833 uk-cd-pres:Director4 2024-07-31 10846833 uk-cd-pres:Director5 2023-08-01 2024-07-31 10846833 uk-cd-pres:Director5 2024-07-31 10846833 uk-cd-pres:AllOrdinaryShares 2024-07-31 10846833 uk-cd-pres:AllPreferenceShares 2024-07-31 10846833 uk-cd-pres:AllOrdinaryShares 2023-07-31 10846833 uk-cd-pres:AllPreferenceShares 2023-07-31 10846833 uk-cd-pres:AllOrdinaryShares 2023-08-01 2024-07-31 10846833 uk-cd-pres:AllPreferenceShares 2023-08-01 2024-07-31 10846833 uk-cd-pres:AllOrdinaryShares 2022-08-01 2023-07-31 10846833 uk-cd-pres:AllPreferenceShares 2022-08-01 2023-07-31 10846833 uk-cd-pres:RegisteredOffice 2023-08-01 2024-07-31 10846833 uk-cd-pres:EntityAccountantsOrAuditors 2024-07-31 10846833 uk-cd-pres:EntityAccountantsOrAuditors 2023-08-01 2024-07-31 10846833 uk-cd-pres:EntityAccountantsOrAuditors 2022-08-01 2023-07-31 10846833 uk-cd-pres:EntityBankers 2023-08-01 2024-07-31 10846833 uk-cd-pres:EntityLawyersOrLegalAdvisers 2023-08-01 2024-07-31 10846833 uk-countries:UnitedKingdom 2023-08-01 2024-07-31 10846833 uk-countries:Europe 2023-08-01 2024-07-31 10846833 uk-countries:NorthAmerica 2023-08-01 2024-07-31 10846833 uk-countries:OtherCountriesRegions 2023-08-01 2024-07-31 10846833 uk-countries:UnitedKingdom 2022-08-01 2023-07-31 10846833 uk-countries:Europe 2022-08-01 2023-07-31 10846833 uk-countries:NorthAmerica 2022-08-01 2023-07-31 10846833 uk-countries:OtherCountriesRegions 2022-08-01 2023-07-31 10846833 uk-gaap-pt:OwnedOrFreeholdTangibleFixedAssets 2023-08-01 2024-07-31 10846833 uk-gaap-pt:LeasedTangibleFixedAssets 2023-08-01 2024-07-31 10846833 uk-gaap-pt:OwnedOrFreeholdTangibleFixedAssets 2022-08-01 2023-07-31 10846833 uk-gaap-pt:LeasedTangibleFixedAssets 2022-08-01 2023-07-31 10846833 uk-gaap-pt:OwnedAssets 2023-08-01 2024-07-31 10846833 uk-gaap-pt:LeasedAssets 2023-08-01 2024-07-31 10846833 uk-gaap-pt:OwnedAssets 2022-08-01 2023-07-31 10846833 uk-gaap-pt:LeasedAssets 2022-08-01 2023-07-31 10846833 uk-gaap-pt:LeasedAssetsHeldAsLessee 2024-07-31 10846833 uk-gaap-pt:LeasedAssetsHeldAsLessee 2023-07-31 10846833 uk-gaap-pt:LeasedAssetsHeldAsLessee 2023-08-01 2024-07-31 10846833 uk-gaap-pt:LeasedAssetsHeldAsLessee 2022-08-01 2023-07-31 10846833 uk-gaap-pt:NetGoodwill 2023-07-31 10846833 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2023-07-31 10846833 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2023-07-31 10846833 uk-gaap-pt:OtherResidualIntangibleAssets 2023-07-31 10846833 uk-gaap-pt:NetGoodwill 2023-08-01 2024-07-31 10846833 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2023-08-01 2024-07-31 10846833 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2023-08-01 2024-07-31 10846833 uk-gaap-pt:OtherResidualIntangibleAssets 2023-08-01 2024-07-31 10846833 uk-gaap-pt:NetGoodwill 2024-07-31 10846833 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2024-07-31 10846833 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2024-07-31 10846833 uk-gaap-pt:OtherResidualIntangibleAssets 2024-07-31 10846833 uk-gaap-pt:Buildings 2023-08-01 2024-07-31 10846833 uk-gaap-pt:Land 2023-08-01 2024-07-31 10846833 uk-gaap-pt:LandBuildings 2023-07-31 10846833 uk-gaap-pt:PlantMachinery 2023-07-31 10846833 uk-gaap-pt:FurnitureFittings 2023-07-31 10846833 uk-gaap-pt:FurnitureFittings 2023-07-31 10846833 uk-gaap-pt:OfficeEquipment 2023-07-31 10846833 uk-gaap-pt:Vehicles 2023-07-31 10846833 uk-gaap-pt:LandBuildings 2023-08-01 2024-07-31 10846833 uk-gaap-pt:PlantMachinery 2023-08-01 2024-07-31 10846833 uk-gaap-pt:FurnitureFittings 2023-08-01 2024-07-31 10846833 uk-gaap-pt:FurnitureFittings 2023-08-01 2024-07-31 10846833 uk-gaap-pt:OfficeEquipment 2023-08-01 2024-07-31 10846833 uk-gaap-pt:Vehicles 2023-08-01 2024-07-31 10846833 uk-gaap-pt:LandBuildings 2024-07-31 10846833 uk-gaap-pt:PlantMachinery 2024-07-31 10846833 uk-gaap-pt:FurnitureFittings 2024-07-31 10846833 uk-gaap-pt:OfficeEquipment 2024-07-31 10846833 uk-gaap-pt:Vehicles 2024-07-31 10846833 uk-gaap-ptx:AdministrativeExpenses 2023-08-01 2024-07-31 10846833 uk-gaap-ptx:AdministrativeExpenses 2022-08-01 2023-07-31 10846833 uk-gaap-ptx:CostSales 2023-08-01 2024-07-31 10846833 uk-gaap-ptx:CostSales 2022-08-01 2023-07-31 10846833 uk-gaap-ptx:DistributionCosts 2023-08-01 2024-07-31 10846833 uk-gaap-ptx:DistributionCosts 2022-08-01 2023-07-31 10846833 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2024-07-31 10846833 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2023-07-31 10846833 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2024-07-31 10846833 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2023-07-31 10846833 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2024-07-31 10846833 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2023-07-31 10846833 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2024-07-31 10846833 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2023-07-31 10846833 uk-gaap-pt:CurrentFinancialInstruments 2024-07-31 10846833 uk-gaap-pt:CurrentFinancialInstruments 2023-07-31 10846833 uk-gaap-pt:WithinOneYear 2024-07-31 10846833 uk-gaap-pt:BetweenOneTwoYears 2024-07-31 10846833 uk-gaap-pt:BetweenTwoFiveYears 2024-07-31 10846833 uk-gaap-pt:MoreThanFiveYears 2024-07-31 10846833 uk-gaap-pt:AfterOneYear 2024-07-31 10846833 uk-gaap-pt:WithinOneYear 2023-07-31 10846833 uk-gaap-pt:BetweenOneTwoYears 2023-07-31 10846833 uk-gaap-pt:BetweenTwoFiveYears 2023-07-31 10846833 uk-gaap-pt:MoreThanFiveYears 2023-07-31 10846833 uk-gaap-pt:AfterOneYear 2023-07-31 10846833 uk-gaap-pt:ShareCapital 2024-07-31 10846833 uk-gaap-pt:SharePremium 2024-07-31 10846833 uk-gaap-pt:RetainedEarningsAccumulatedLosses 2024-07-31 10846833 uk-gaap-pt:RevaluationReserve 2024-07-31 10846833 uk-gaap-pt:OtherReservesSubtotal 2024-07-31 10846833 uk-gaap-pt:ShareCapital 2023-07-31 10846833 uk-gaap-pt:SharePremium 2023-07-31 10846833 uk-gaap-pt:RetainedEarningsAccumulatedLosses 2023-07-31 10846833 uk-gaap-pt:RevaluationReserve 2023-07-31 10846833 uk-gaap-pt:OtherReservesSubtotal 2023-07-31 10846833 1 2023-08-01 2024-07-31 10846833 2 2023-08-01 2024-07-31 10846833 uk-cd-pres:FRS102 2023-08-01 2024-07-31 10846833 uk-cd-pres:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 10846833 uk-cd-pres:FullAccounts 2023-08-01 2024-07-31 10846833 uk-cd-pres:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 iso4217:GBP xbrli:pure
 
 
 
 
 
 
 
EVOLUTION AESTHETICS CLINIQUE LTD
 
 
Company Registration Number
10846833
 
 
Report of the Directors and
Abridged Unaudited Financial Statements
 
 
Period of accounts
 
Start date 01/08/2023
 
End date 31/07/2024
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 1
EVOLUTION AESTHETICS CLINIQUE LTD
 
Contents of the Financial Statements
for the Period Ended 31 July 2024
 
 
Page
Company Information 3
 
Abridged Balance Sheet 4 - 5
 
Notes to the Financial Statements 6 - 8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 2
EVOLUTION AESTHETICS CLINIQUE LTD
Company Information
for the Period Ended 31 July 2024
 
Directors Alina- Rodica Crisan
 
 
Registered office 1 The Summit
Loughton
IG10 1SW
 
Company Registration Number 10846833
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 3
EVOLUTION AESTHETICS CLINIQUE LTD
Balance Sheet
for the Period Ended 31 July 2024
Company registration number 10846833
2024 2,023
Notes £ £
Current assets
Cash at bank and in hand 1,045
_______ _______
Total current assets/(liabilities) 1,045 0
Creditors
Net current assets 1,045 0
_______ _______
Total assets less current liabilities 1,045 0
_______ _______
Creditors - amounts falling
due after more than one year 2 11,963 0
_______ _______
Long term creditors 11,963 0
______ __
Net assets/(liabilities) (10,918) 0
Capital and reserves
Called up share capital 3 1
Profit and loss account 4 (10,919)
______ _
Total shareholders funds (10,918) 0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 4
EVOLUTION AESTHETICS CLINIQUE LTD
 
Balance Sheet
for the Period Ended 31 July 2024
 
 
 
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The option not to file the profit and loss account has been taken.
 
For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
 
The financial statements were approved by the Board of Directors on 2025-04-26
 
SIGNED ON BEHALF OF THE BOARD BY
 
 
 
 
 
 
 
Name Alina- Rodica Crisan
Status Director
 
The notes form part of these financial statements
Average number of employees during period 0
 
 
 
 
 
 
 
Page 5
EVOLUTION AESTHETICS CLINIQUE LTD
Notes to the Financial Statements
for the Period Ended 31 July 2024
1. Accounting policies
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with the small companies regime.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 6
EVOLUTION AESTHETICS CLINIQUE LTD
Notes to the Financial Statements
for the Period Ended 31 July 2024
2. Creditors amounts falling due after more than one year 2024 2,023
Bank loans 11,963
_____ _
Total 11,963 0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 7
EVOLUTION AESTHETICS CLINIQUE LTD
Notes to the Financial Statements
for the Period Ended 31 July 2024
3. Share capital 2024 2,023
Authorised type Par value £ £
Ordinary 1 100 100
___ ___
Total 100 100
Allotted, called up and paid £ £
Ordinary 1
_ _
Total 1
4. Reserves/Retained profit
Retained profit reconciliation £
Reserves at 1 August 2023
Profit/(Loss) for year (10,919)
Dividends paid
______
Retained Profit/(Loss) at 31 July 2024 (10,919)
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 8